Ozempic Penis ‘Is a Thing’: Dr Terry Dubrow Announces and It’s the Antidote to ‘Buried Penis Syndrome’
Dr Terry Dubrow announced a new Ozempic-related disorder, which he called ‘Ozempic penis,’ where one’s member ‘looks bigger’ while taking the GLP-1 medication.
CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks
The government on Tuesday announced final prices for the second round of drugs negotiated by Medicare under the Inflation Reduction Act, including for Novo Nordisk’s blockbuster weight loss drugs Ozempic and Wegovy. The negotiated prices …
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds
By mid-2024, the weight-loss drugs were prescribed for almost 2 percent of new mothers.
Confronting the Global Rise of Obesity and Cardiovascular Disease: The Role of GLP-1 RAs
Publication date: 2 December 2025 Source: JACC, Volume 86, Issue 22 Author(s): Erica S. Spatz
GLP-1 users to make up 35% of food and beverage sales by 2030: report
As more consumers take weight loss medications like Ozempic or Wegovy, companies will need to act fast if they want to adapt, according to Circana.
Novo Nordisk GLP-1 fails to slow Alzheimer’s in trials
Novo Nordisk’s GLP-1 drug semaglutide did not demonstrate a statistically significant effect in slowing progression of Alzheimer’s disease in two late-stage clinical trials. According to a Nov. 24 news release from the company, two double-blinded, placebo-controlled phase 3 trials enrolled 3,808 adults ages 55-85 with mild cognitive impairment or mild dementia. Over a two-year period, […]
Redditors Are Buying Eli Lilly And Co (LLY) Ahead of Potential End of AI Trade. Here’s Why
We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. Eli Lilly And Co (NYSE:LLY) is one of the top non-AI stocks redditors are buying. Eli Lilly And Co (NYSE:LLY) recently posted strong quarterly results amid robust growth from its diabetes and weight-loss products. With a diverse portfolio spanning oncology, […]
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
NATICK, Mass.–(BUSINESS WIRE)—- $ALUR–Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to optimize muscle mass and GLP-1 adherence. 76 patients treated with the Allurion Smart Capsule were started on low-dose tirzepatide after […]
Pill form of semaglutide fails to slow Alzheimer’s in large trial
A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer’s disease, drugmaker Novo Nordisk announced on Nov. 24.
Gut health, GLP-1 and AI – the issues shaping ingredients and NPD – Yahoo
Gut health, GLP-1 and AI – the issues shaping ingredients and NPD Yahoo